Type 2 Diabetes: Principles and Practice, Second EditionBarry J. Goldstein, Dirk Mueller-Wieland CRC Press, 19 abr 2016 - 608 páginas The incidence and prevalence of type 2 diabetes mellitus have increased dramatically in modernized and developing nations over the past few decades. Thoroughly revised and expanded, this Second Edition responds to the epidemic and supplies a current overview and guide to the management of diabetes in the modern healthcare environment. This Second E |
Índice
| 1 | |
| 13 | |
Chapter 3 Rationale and Goals for Glucose Control in Diabetes Mellitus and Glucose Monitoring | 27 |
Chapter 4 The Role of the Diabetes Educator in the Education and Management of Diabetes Mellitus | 45 |
Chapter 5 Nutrition in the Etiology and Management of Type 2 Diabetes | 59 |
Chapter 6 Diabetes and Exercise | 73 |
Chapter 7 Psychosocial Issues and Type 2 Diabetes | 83 |
Sulfonylureas and Meglitinides | 97 |
Chapter 22 Gastrointestinal and Autonomic Complications of Diabetes Mellitus | 327 |
Chapter 23 Gestational Diabetes | 341 |
Chapter 24 Epidemiology of Type 2 Diabetes in Children and Adolescents | 357 |
Chapter 25 Insulin Resistance Syndrome and Its Vascular Complications | 375 |
Influence on Diabetes and Management | 395 |
Chapter 27 Dyslipidemia and Diabetes | 405 |
Need for Combination Therapy | 417 |
Chapter 29 The Evaluation of Cardiac and Peripheral Arterial Disease in Patients with Diabetes Mellitus | 437 |
Chapter 9 Metformin | 107 |
Chapter 10 AlphaGlucosidase Inhibitors | 121 |
Chapter 11 Thiazolidinediones | 135 |
Chapter 12 Treatment Strategies for Type 2 Diabetes Based on Incretin Action | 159 |
Chapter 13 Pramlintide Acetate in the Treatment of Type 2 Diabetes | 171 |
Chapter 14 Insulin Therapy in Type 2 Diabetes | 181 |
Chapter 15 Combination Therapy for Treatment of Type 2 Diabetes | 207 |
Chapter 16 Hypoglucemia in Type 2 Diabetes | 227 |
Current Therapy of Diabetic Ketoacidosis and NonKetoacidotic Hyperosmolar Coma | 237 |
Chapter 18 Diabetic Retinopathy and Ocular Complications | 251 |
Chapter 19 Renal Dysfunction and Hypertension | 263 |
Chapter 20 Diabetic Peripheral Neuropathy and Sexual Dysfunction | 277 |
Chapter 21 Diabetic Foot Ulcers | 313 |
Chapter 30 Acute Coronary Syndrome Myocardial Infarction Heart Failure and Stable Coronary Artery Disease Specific Considerations in Diabetes | 463 |
Chapter 31 Anesthesia and Surgery in the Diabetic Patients | 475 |
Geriatric Considerations | 491 |
Chapter 33 Diabetes in HighRisk Ethnic Populations | 501 |
Chapter 34 DrugInduced Hyperglucemia and Diabetes Mellitus | 513 |
Lessons from Monogenetic Diabetes Forms | 529 |
Chapteer 36 Polycystic Ovary Syndrome and the Metabolic Snydrome | 537 |
Chapter 37 Nonalcoholic Fatty Liver Disease and Diabetes Mellitus | 553 |
New Devices on the Horizon for Glucose Monitoring and Medication Delivery | 561 |
| 575 | |
Back cover | 595 |
Otras ediciones - Ver todo
Type 2 Diabetes: Principles and Practice, Second Edition Barry J. Goldstein,Dirk Mueller-Wieland No hay ninguna vista previa disponible - 2007 |
Type 2 Diabetes: Principles and Practice, Second Edition Barry J Goldstein,Dirk Mueller-Wieland No hay ninguna vista previa disponible - 2019 |
Términos y frases comunes
achieve action activity addition agents American artery associated blood glucose blood pressure body cardiovascular cause cells changes Clin clinical combination compared complications concentrations coronary decreased diabetes mellitus diabetic ketoacidosis diabetic patients diet disease dose drug dysfunction early effects et al exercise factors function glucose tolerance glycemic control HbA1c heart human hypertension hypoglycemia impaired important improved incidence increased individuals inhibitors injection insulin resistance insulin sensitivity intensive lead levels long-term loss lower major measures mechanisms Metab metabolic metformin mortality myocardial infarction neuropathy normal obesity oral outcomes pain patients with diabetes patients with type peripheral placebo plasma population postprandial prevalence prevention progression randomized recent recommended reduced renal reported response risk role secretion severe showed shown significant subjects suggest sulfonylurea symptoms syndrome Table therapy tissue treated treatment trial type 2 diabetes weight women